• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD

by Fred Pennic 06/19/2020 Leave a Comment

Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD

What You Should Know:

– Digital therapeutics company Kaia Health raises $26M in Series B funding to help grow its digital therapy solutions for musculoskeletal (MSK) conditions, and expand into new conditions.

– The investment was led by Optum Ventures, Idinvest and capital300, plus participation from Balderton Capital, Heartcore Capital and Symphony Ventures, an investment partnership with world #1 golfer Rory McIlroy.

– Kaia Health’s smartphone-based approach to managing chronic conditions uses a proprietary 2D motion tracking technology which, when combined with the platform’s psychological and educational support, has been clinically proven to outperform conventional therapy, as shown in three published peer-reviewed clinical trials.


Kaia Health, a digital therapeutics company focused on helping people manage chronic conditions, today announced that it closed a $26 million Series B funding round, bringing its total funds raised to date to $50 million. The round was led by Optum Ventures, Idinvest, and capital300 with participation from existing investors Balderton Capital and Heartcore Capital, as well as Symphony Ventures (an investment partnership with world #1 golfer Rory McIlroy). 

The Gold Standard in Pain Therapy – Digitalized

A sedentary lifestyle and long office hours take their toll with 11.4 workdays lost per person on average, according to the US Bone and Joint Initiative. Founded in 2016, Kaia Health utilizes multimodal therapy, which combines physical, psychological and educational elements to relieve back pain at home, without medication. Kaia Health’s world-leading smartphone-based 2D motion tracking solution named Motion Coach enables users to get real-time feedback on their exercise performance using their smartphone’s camera, which, when taken together with the platform’s psychological and educational support has been proven to outperform conventional therapy.

Drive Growth of Core Digital Therapy Solutions

Kaia Health will use the proceeds to drive the growth of its core digital therapy solutions for people managing musculoskeletal (MSK) conditions, and fund expansion into new conditions such as COPD, where its digitally delivered multi-modal therapy is also clinically effective. The platform has served over 400,000 users in just four years since launch, and today is the most utilized global digital therapeutics platform.

The company will continue to invest in its proprietary technology and build on its standing as the industry leader in global 2D motion tracking – which enables users to get real-time feedback on exercise performance using their smartphone’s camera – while moving towards a 3D musculoskeletal model. Kaia also will continue investing heavily in clinical research, and expand its team to accelerate employer and health plan growth.

“Similar to the explosion we’ve seen in doctor to patient telehealth, the healthcare challenges arising from COVID has also highlighted the need for new care delivery models,” said Kaia Founder and President Konstantin Mehl. “This has accelerated adoption of new approaches to care, such as those we’re developing at Kaia, which were already showing great promise. We are excited by the opportunity to drive our business forward given heightened awareness of the merits of digital therapies among payers, companies, care providers and consumers, and the growing importance of delivering care in the home. We believe we are on the precipice of moving our solutions from the early adopter set to mass market, and this funding will help us aggressively expand the reach and impact of our platform.”

RELATED:   Meaningful Use of Genomics Requires Informatics Beyond EMRs

Tagged With: AI, clinical research, Clinical Trials, COPD, Digital Therapeutics, Kaia Health, medication, model, Optum, Optum Ventures, Payers, telehealth

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« DrFirst, MARQUIS Med Rec Partner to Help Hospitals Improve Patient Safety Through Better Medication Reconciliation
ACO to Deploy Innovaccer’s FHIR-enabled Data Activation Platform Across Medicare Population »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • To Beat COVID-19, We Need A Modern Approach to Public Health Data

    To Beat COVID-19, We Need A Modern Approach to Public Health Data

    ... more
  • HealthStream Acquires Policy Management System ComplyALIGN for $2M

    HealthStream Acquires Policy Management System ComplyALIGN for $2M

    ... more
  • Technologies That Are Transforming the Nursing Profession

    4 Technologies That Are Transforming the Nursing Profession

    ... more
  • mPulse Mobile Acquires Digital Health Engagement Company Big Know

    mPulse Mobile Acquires Digital Health Engagement Company The Big Know

    ... more

Most Read

  • Philips Acquires Medical Device Integration Platform Capsule for $635M Philips Acquires Medical Device Integration Platform Capsule for $635M
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 20 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • DPHO, UnitedHealthcare Launch Accountable Care Program UnitedHealth Rolls Out Employer Virtual Primary Care Plan
  • 3 Steps to Maintain Telehealth’s Momentum Post-Pandemic 3 Steps to Maintain Telehealth’s Momentum Post-Pandemic
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |